In another study, siRNA targeting ataxia-telangiectasia and rad3-related (ATR) and the chemotherapeutic drug DOX were co-loaded in ZIF-8 NPs to modulate tumor gene expression profiles. The gene discussed is ATR; the disease is neoplasm.